Tetrabenazinum
compositum chemicum
 |
Cave: notitiae huius paginae nec praescriptiones nec consilia medica sunt. |
| Cognitores | |
|---|---|
| ChemSpider | 5796 |
| PubChem | 6018 |
| DrugBank | DB04844 |
| Natura chemica | |
| |
| Formula summarum | C 19H 27NO 3 |
| Massa molaris | 317.427 g/mol |
| Natura pharmacologica | |
| Codex ATC | N07XX06 (WHO) |
| Metabolismus | iecore (hepaticus) |
| Excretio | renibus: 75%, faecibus: 7-16% |
| Ad usum therapeuticum | |
| Applicatio | per os |
Tetrabenazinum est medicamentum in malis motuum hyperkineticis tractandis, ut morbo Huntington et dystoniis atque dyskinesia tardiva.
Natura Tetrabenazini recensere
Natura chemica recensere
Tetrabenazinum est (IUPAC) (RR,SS)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo-[a]-chinolinum.
Massa molaris est 317.427 g/mol.
Natura pharmacologica recensere
Pharmacodynamica recensere
Tetrabenazinum receptoria dopamini obsidet inhibetque. Praeterea neurotransmissores monoaminergicos consumit.
Pharmacocinetica recensere
Excretio est per imprimis urinas, minus per biles.
Effectus Tetrabenazini recensere
Effectus secundarii recensere
Exempli (!) sunt[1]:
Nexus interni
Notae recensere
- ↑ Jankovic J., Beach J. (Feb 1997). "Long-term effects of tetrabenazine in hyperkinetic movement disorders". Neurology 48 (2): 385-62